Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1

被引:0
|
作者
Mingjian Lu
Min Wan
Karla F Leavens
Qingwei Chu
Bobby R Monks
Sully Fernandez
Rexford S Ahima
Kohjiro Ueki
C Ronald Kahn
Morris J Birnbaum
机构
[1] The Institute for Diabetes,Department of Diabetes and Metabolic Diseases
[2] Obesity and Metabolism,Research Division
[3] Perelman School of Medicine,undefined
[4] University of Pennsylvania,undefined
[5] Graduate School of Medicine,undefined
[6] University of Tokyo,undefined
[7] Joslin Diabetes Center,undefined
[8] Harvard Medical School,undefined
来源
Nature Medicine | 2012年 / 18卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The insulin signaling pathway regulating glucose homeostasis that has been well accepted is insulin-to-insulin receptor-to-IRS proteins-to-PI3K-to-Akt-to-Foxo1—a pathway that does not respond properly in states of insulin resistance, including type 2 diabetes. In a new study from Morris Birnbaum and colleagues, an alternative insulin signaling pathway has been uncovered, as mice with liver-specific deletion of Akt and Foxo1 still respond normally to nutritional cues and properly regulate glucose metabolism. Although the exact nature of this alternative pathway needs to be identified, the results should open many new avenues of exploration in the field of type 2 diabetes.
引用
收藏
页码:388 / 395
页数:7
相关论文
共 50 条
  • [1] Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1
    Lu, Mingjian
    Wan, Min
    Leavens, Karla F.
    Chu, Qingwei
    Monks, Bobby R.
    Fernandez, Sully
    Ahima, Rexford S.
    Ueki, Kohjiro
    Kahn, C. Ronald
    Birnbaum, Morris J.
    [J]. NATURE MEDICINE, 2012, 18 (03) : 388 - U254
  • [2] Foxo1 in hepatic lipid metabolism
    Cheng, Zhiyong
    White, Morris F.
    [J]. CELL CYCLE, 2010, 9 (02) : 219 - 220
  • [3] FoxO1 and hepatic lipid metabolism
    Sparks, Janet D.
    Dong, Henry H.
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2009, 20 (03) : 217 - 226
  • [4] MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1
    Luo, Ailing
    Yan, Haibo
    Liang, Jichao
    Du, Chunyuan
    Zhao, Xuemei
    Sun, Lijuan
    Chen, Yong
    [J]. GENE, 2017, 627 : 194 - 201
  • [5] Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism
    Matsumoto, Michihiro
    Han, Seongah
    Kitamura, Tadahiro
    Accili, Domenico
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (09): : 2464 - 2472
  • [6] Foxo1 links insulin signaling to C/EBPα and regulates gluconeogenesis during liver development
    Sekine, Keisuke
    Chen, Yen-Rong
    Kojima, Nobuhiko
    Ogata, Kazuhiro
    Fukamizu, Akiyoshi
    Miyajima, Atsushi
    [J]. EMBO JOURNAL, 2007, 26 (15): : 3607 - 3615
  • [7] Deregulation of FoxO1 and insulin signaling associated with steatohepatitis and hepatic insulin resistance
    Valenti, Luca
    Rametta, Raffaela
    Dongiovanni, Paola
    Roviaro, Giancarlo
    Maggioni, Marco
    Fargion, Silvia
    [J]. DIABETES, 2007, 56 : A345 - A345
  • [8] Glucagon Regulates Hepatic Mitochondrial Biogenesis and Function through Foxo1
    Yang, Wanbao
    Yan, Hui
    Pan, Quan
    Shen, Zheng
    Dahanayaka, Sudath A.
    Wu, Chaodong
    Sun, Yuxiang
    Guo, Shaodong
    [J]. DIABETES, 2018, 67
  • [9] Glucagon regulates hepatic mitochondrial function and biogenesis through FOXO1
    Yang, Wanbao
    Yan, Hui
    Pan, Quan
    Shen, James Zheng
    Zhou, Fenghua
    Wu, Chaodong
    Sun, Yuxiang
    Guo, Shaodong
    [J]. JOURNAL OF ENDOCRINOLOGY, 2019, 241 (03) : 265 - 278
  • [10] FoxO1 increase hepatic insulin sensitivity via inhibition of TRB-3, a negative modulator of Akt
    Matsumoto, M
    Kitamura, T
    Kitamura, Y
    Accili, D
    [J]. DIABETES, 2005, 54 : A53 - A53